Lv1
60 积分 2025-08-30 加入
Letermovir Improves Real-World, 5-Year Overall Survival Among CMV Seropositive Allogeneic Hematopoietic Cell Transplant Recipients
1个月前
已完结
A new direction for cytomegalovirus prophylaxis among transplant recipients: Benefits and nonviral outcomes of letermovir use as primary CMV prophylaxis
1个月前
已完结
皖公网安备34019202002308
